Clinical, biomechanical, and biochemical research continues to reveal important findings regarding CTFDD treatment. The
validity of Cox Technic Flexion Distraction
Decompression (CTFDD)
spinal manipulation has support via studies that have shown notable reductions in intradiscal pressure, changes in spinal reflex excitability, and improvements in vertebral motion, which lead to increased disc space height, area, and width, as well as enhanced spinal mobility. Additional findings include advancements in intervertebral disc spectral features observed through magnetic spectroscopy, demonstrating a reduction in biochemical pain markers and an increase in glycoprotein production. Furthermore, recent data highlight the forces applied during CTFDD treatment and report a significant decrease in opioid usage among patients with failed back surgical syndrome undergoing this therapy. (1-8) The
reliability of CTFDD has been supported by numerous case reports, case series, and a randomized clinical trial, demonstrating its effectiveness across a range of spinal conditions. These include disc herniation, spondylolisthesis,
failed back surgical syndrome, spinal stenosis, chronic low back pain, and radiculopathy. (9-20)